215 related articles for article (PubMed ID: 2217009)
21. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
[TBL] [Abstract][Full Text] [Related]
22. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.
Charnvises K; Weerakiet S; Tingthanatikul Y; Wansumrith S; Chanprasertyothin S; Rojanasakul A
Gynecol Endocrinol; 2005 Sep; 21(3):161-4. PubMed ID: 16335908
[TBL] [Abstract][Full Text] [Related]
23. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.
Reyes-Muñoz E; Ortega-González C; Martínez-Cruz N; Arce-Sánchez L; Estrada-Gutierrez G; Moran C; Sánchez-Serrano AP; Higareda-Sánchez R; de la Jara-Díaz JF
BMJ Open; 2016 Jul; 6(7):e012107. PubMed ID: 27449893
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and significance of acanthosis nigricans in an adult obese population.
Hud JA; Cohen JB; Wagner JM; Cruz PD
Arch Dermatol; 1992 Jul; 128(7):941-4. PubMed ID: 1626961
[TBL] [Abstract][Full Text] [Related]
25. [Acanthosis nigricans: metabolic interrelations inherent to the polycystic ovary syndrome].
de Ávila MA; Borges LP; Paez MS; Bruno RV; Nardi AE; de Pessôa AC; Palmeira Ede S
Rev Bras Ginecol Obstet; 2014 Sep; 36(9):410-5. PubMed ID: 25272362
[TBL] [Abstract][Full Text] [Related]
26. Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.
Mahabeer S; Naidoo C; Joubert SM
Diabetes Res; 1990 Jun; 14(2):79-82. PubMed ID: 2134217
[TBL] [Abstract][Full Text] [Related]
27. Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS).
Kinoshita T; Kato J
Horm Res; 1990; 33 Suppl 2():18-20. PubMed ID: 2095356
[TBL] [Abstract][Full Text] [Related]
28. The syndrome of acanthosis nigricans, hyperandrogenism and insulin resistance.
Tatnall FM; Graham-Brown RA; Dandona P; Sarkany I
Clin Exp Dermatol; 1984 Sep; 9(5):526-31. PubMed ID: 6488585
[No Abstract] [Full Text] [Related]
29. Insulin resistance in obese adolescents.
Li HJ; Huang CY; Lee HC; Chen MR; Lo FS; Lin CH; Wang AM; Shih BF; Lee YJ
Acta Paediatr Taiwan; 2005; 46(2):61-6. PubMed ID: 16302580
[TBL] [Abstract][Full Text] [Related]
30. Acanthosis nigricans and oral glucose tolerance in obese children.
Scott AT; Metzig AM; Hames RK; Schwarzenberg SJ; Dengel DR; Biltz GR; Kelly AS
Clin Pediatr (Phila); 2010 Jan; 49(1):69-71. PubMed ID: 19706878
[No Abstract] [Full Text] [Related]
31. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
32. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.
Galhardo J; Hunt LP; Shield JP
Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782
[TBL] [Abstract][Full Text] [Related]
34. [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].
Fu JF; Liang L; Dong GP; Jiang YJ; Zou CC
Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):917-9. PubMed ID: 15733362
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance with acanthosis nigricans and acral hypertrophy.
Holdaway IM; Frengley PA; Graham FM; Wong M
N Z Med J; 1984 May; 97(755):286-8. PubMed ID: 6587221
[TBL] [Abstract][Full Text] [Related]
37. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.
Tan TT; Lui SK; Satgunasingam N; Khalid BA
Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038
[TBL] [Abstract][Full Text] [Related]
38. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
[TBL] [Abstract][Full Text] [Related]
39. The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
Pasquali R; Casimirri F; Balestra V; Flamia R; Melchionda N; Fabbri R; Barbara L
J Endocrinol Invest; 1991 Nov; 14(10):839-46. PubMed ID: 1802922
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans].
Liang XJ; Zhu C; Yan C; Ni GC; Liu ZL; Du ZM; Li M
Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):405-7. PubMed ID: 15265420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
